Specialty drugs, biologics have side effects for employers – soaring costs

Canadian HR Reporter (May 2011)

Employers are facing some tough realities and tough decisions when it comes to health benefit plans because of a rising tide of very expensive, non-traditional or specialty drug therapies. View post


Why Generic Drug Pricing Legislation is Not Enough

May 2011

Breakfast Benefits Club, Barrie


Realizing Savings within Your Existing Benefit Plans

May 2011

Council of Ontario Senior Business Officials Conference, Niagara-on-the-Lake


March/April 2011 – Benefits Intelligence: The need for data-mining in benefit plans

May 2011

IN THIS ISSUE...Breakthrough in Multiple Sclerosis treatment...NOC Watch: Vimovo, Revolade...FEATURE: Benefits Intelligence: The need for data-mining in benefit plans...Highlights from Cubic Health's February presentations View post


January/February 2011 – The Promise of 2011

May 2011

IN THIS ISSUE...Update of the CADTH Biologics Review in Rheumatoid Arthritis...The link between autism and vaccines...NOC Watch: Vitaros, Daxas...What can the VA system teach Canadian plan sponsors? View post


Latest News